Our results demonstrate that loss-of-function variants in JPH1, coding for junctophillin-1, result in a congenital myopathy, characterised by global distribution of muscle weakness and wasting, but with prominent facial muscle weakness, bilateral ptosis, exercise intolerance and fatigability. Here, JPH1 is linked to congenital myopathy.